ASPN
ASPN
NYSE · Chemicals

Aspen Aerogels Inc

$3.45
-0.02 (-0.58%)
Financial Highlights (FY 2026)
Revenue
283.93M
Net Income
-407,987,121
Gross Margin
17.0%
Profit Margin
-143.7%
Rev Growth
+14.5%
D/E Ratio
0.51
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 17.0% 17.0% 57.3% 57.3%
Operating Margin -139.5% -125.6% 18.7% 16.7%
Profit Margin -143.7% -136.5% 13.6% 15.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 283.93M 247.89M 146.35M 128.99M
Gross Profit 48.18M 42.07M 83.93M 73.97M
Operating Income -396,107,562 -311,242,191 27.30M 21.58M
Net Income -407,987,121 -320,576,574 19.84M 19.55M
Gross Margin 17.0% 17.0% 57.3% 57.3%
Operating Margin -139.5% -125.6% 18.7% 16.7%
Profit Margin -143.7% -136.5% 13.6% 15.2%
Rev Growth +14.5% +14.5% +7.3% +15.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 47.69M 47.69M 91.90M 96.56M
Total Equity 94.14M 94.14M 125.53M 123.58M
D/E Ratio 0.51 0.51 0.73 0.78
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -346,957,621 -287,768,238 43.43M 31.39M
Free Cash Flow 18.52M 15.91M